Share this post on:

Product Name :
Sotorasib

Search keywords :
Sotorasib

drugId :
null

Target Vo:
KRAS G12C

Target Vo Short Name :
KRAS G12C

Moa_Name:
KRAS G12C inhibitors

First Approval Country :
United States

First Approval Date Filter:
2021

Origin Company_Name :
Amgen Inc

Active Company_Name :
Amgen Biotechnology Consultation (Shanghai) Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AKT1 (Ser473) Antibody
FOXA2 Antibody
Phospho-Src (Tyr419) Antibody: Phospho-Src (Tyr419) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to Phospho-Src(Y419). It can be used for WB,FC assays with tag free, in the background of Human.

Share this post on:

Author: Betaine hydrochloride